Pictura Bio is a medical technology company developing a one-minute pathogen detection platform utilizing proprietary hardware and computer vision for infectious disease diagnostics. Its point-of-care system, which includes the PIC-ID and VISTA reader technologies, provides rapid identification and differentiation of pathogens to assist frontline healthcare providers.
Subscribe to see Pictura Bio US, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Pictura Bio US, Inc. is a medical devices & healthcare company headquartered in United Kingdom. Its most recent funding round, Pre-Seed, raised $9.1M in January 2026. Xcout tracks 9 named people at Pictura Bio US, Inc., including Alex Batchelor (Chief Executive Officer).
As of 20 November 2026. Source: Xcout Intel.
3 more named people on record for Pictura Bio US, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Pre-Seed | $9.1M | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Pictura Bio US, Inc.'s closest competitors — see the full list of competitors and alternatives →
Based in Adelaide, Australia, Clever Culture Systems Limited, established in 2004, focuses on the innovation, development, and market launch of advanced technological solutions for the medical industry. The company operates internationally, serving markets in Australia, the United States, Sweden, the United Kingdom, China, the Netherlands, and Germany. Its core offering is the Automated Plate Assessment System (APAS), which efficiently images, analyzes, and interprets microbiology culture plates, primarily assisting microbiology laboratories and the pharmaceutical manufacturing sector. The company's portfolio also includes Digital Microbiology and specialized APAS modules—artificial intelligence algorithms designed to enable digital reading of culture plates when integrated with the APAS Independence system. Additionally, Clever Culture Systems is advancing its APAS intelligent imaging technology for diverse applications, including urine screening, infection control testing, and assessing antimicrobial susceptibility. Formerly known as LBT Innovations Limited, the company adopted its current name in November 2024.
NanoSynex is a medical technology company that develops rapid diagnostic systems to test for antibiotic resistance and provide personalized antibiotic treatments. The company serves the healthcare sector by aiming to speed up bacterial diagnosis, improve testing quality, and combat the antibiotics crisis.
Vail Scientific develops medical technology for the rapid, non-invasive, and real-time point-of-care detection of sepsis. The company provides healthcare providers with screening solutions utilizing proprietary nitric oxide technology to identify sepsis early and accelerate treatment.
Magnolia Medical Technologies develops medical devices, such as the Steripath platform, designed to reduce blood culture contamination and improve diagnostic accuracy for sepsis testing. The company serves hospitals, healthcare systems, and clinical professionals by providing solutions that support infection prevention and diagnostic stewardship.
Spartan Bioscience was a Canadian biotechnology and diagnostics company based in Ottawa that developed portable, rapid PCR-based DNA analyzers and associated test kits. Its products were intended for healthcare providers, laboratories, and other organizations needing decentralized testing for infectious diseases and genetic targets, including COVID-19.
NanoEntek Inc. develops and manufactures life science research solutions and in-vitro diagnostic (IVD) medical devices utilizing lab-on-a-chip technology based on MEMS and micro-fluidics. The company provides products such as automated cell counters, electroporation systems, live cell imaging devices, and microfluidic immunofluorescence analyzers to support laboratories and medical professionals.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Pictura Bio US, Inc.? Suggest a correction · Work at Pictura Bio US, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.